Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study.

Grunberg, S M; Crowley, J; Hande, K R; Giroux, D; Munshi, N; Lau, D H; Schroder, L E; Zangmeister, M H; Balcerzak, S P; Hynes, H E; Gandara, D R

Grunberg, S M; Crowley, J; Hande, K R; Giroux, D; Munshi, N; Lau, D H; Schroder, L E; Zangmeister, M H; Balcerzak, S P; Hynes, H E; Gandara, D R.

Affiliation

Grunberg SM; University of Vermont, Burlington, VT, USA.

Cancer Chemother Pharmacol ; 44(6): 461-8, 1999.

Article de En | MEDLINE | ID: mdl-10550566

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome à petites cellules / Tumeurs du poumon Type d'étude: Clinical_trials / Diagnostic_studies / Prognostic_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Chemother Pharmacol Année: 1999 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links